STOCK TITAN

Trueblue Financials

TBI
Source SEC Filings (10-K/10-Q) Updated Dec 28, 2025 Currency USD FYE December

This page shows Trueblue (TBI) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 34 / 100
Financial Profile 34/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability
16

Trueblue has an operating margin of -2.9%, meaning the company retains $-3 of operating profit per $100 of revenue. This below-average margin results in a low score of 16/100, suggesting thin profitability after operating expenses. This is up from -5.9% the prior year.

Growth
39

Trueblue's revenue grew a modest 3.1% year-over-year to $1.6B. This slow but positive growth earns a score of 39/100.

Leverage
97

Trueblue carries a low D/E ratio of 0.24, meaning only $0.24 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 97/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
39

Trueblue's current ratio of 2.15 indicates adequate short-term liquidity, earning a score of 39/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow
14

While Trueblue generated -$58.0M in operating cash flow, capex of $15.7M consumed most of it, leaving -$73.7M in free cash flow. This results in a low score of 14/100, reflecting heavy capital investment rather than weak cash generation.

Returns
0

Trueblue generates a -17.5% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is up from -39.9% the prior year.

Piotroski F-Score Weak
3/9

Trueblue passes 3 of 9 financial strength tests. 1 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Low Quality
1.21x

For every $1 of reported earnings, Trueblue generates $1.21 in operating cash flow (-$58.0M OCF vs -$48.0M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$1.6B
YoY+3.1%
5Y CAGR-2.6%
10Y CAGR-2.9%

Trueblue generated $1.6B in revenue in fiscal year 2025. This represents an increase of 3.1% from the prior year.

EBITDA
-$17.8M
YoY+71.9%

Trueblue's EBITDA was -$17.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 71.9% from the prior year.

Net Income
-$48.0M
YoY+61.9%

Trueblue reported -$48.0M in net income in fiscal year 2025. This represents an increase of 61.9% from the prior year.

EPS (Diluted)
$-1.61
YoY+61.4%

Trueblue earned $-1.61 per diluted share (EPS) in fiscal year 2025. This represents an increase of 61.4% from the prior year.

Cash & Balance Sheet

Free Cash Flow
-$73.7M
YoY-78.9%

Trueblue generated -$73.7M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 78.9% from the prior year.

Cash & Debt
$24.5M
YoY+8.8%
5Y CAGR-17.1%
10Y CAGR+2.2%

Trueblue held $24.5M in cash against $65.8M in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
30M
YoY+1.2%
5Y CAGR-3.3%
10Y CAGR-3.2%

Trueblue had 30M shares outstanding in fiscal year 2025. This represents an increase of 1.2% from the prior year.

Margins & Returns

Gross Margin
22.8%
YoY-3.2pp
5Y CAGR-1.1pp
10Y CAGR-1.9pp

Trueblue's gross margin was 22.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 3.2 percentage points from the prior year.

Operating Margin
-2.9%
YoY+3.0pp
5Y CAGR+6.6pp
10Y CAGR-6.7pp

Trueblue's operating margin was -2.9% in fiscal year 2025, reflecting core business profitability. This is up 3.0 percentage points from the prior year.

Net Margin
-3.0%
YoY+5.0pp
5Y CAGR+4.7pp
10Y CAGR-6.0pp

Trueblue's net profit margin was -3.0% in fiscal year 2025, showing the share of revenue converted to profit. This is up 5.0 percentage points from the prior year.

Return on Equity
-17.5%
YoY+22.4pp
5Y CAGR+15.0pp
10Y CAGR-31.5pp

Trueblue's ROE was -17.5% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 22.4 percentage points from the prior year.

Capital Allocation

R&D Spending
N/A
Share Buybacks
$0
YoY-100.0%

Trueblue spent $0 on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 100.0% from the prior year.

Capital Expenditures
$15.7M
YoY-35.1%
5Y CAGR-10.3%
10Y CAGR-0.8%

Trueblue invested $15.7M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 35.1% from the prior year.

TBI Income Statement

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Revenue $418.2M-3.0% $431.3M+8.8% $396.3M+7.0% $370.3M-4.1% $386.0M+0.9% $382.4M-3.5% $396.2M-1.6% $402.9M
Cost of Revenue $328.1M-1.6% $333.4M+10.1% $302.7M+6.6% $283.9M+0.2% $283.4M+0.4% $282.3M-3.3% $291.8M-3.8% $303.5M
Gross Profit $90.0M-8.0% $97.9M+4.6% $93.6M+8.4% $86.3M-15.8% $102.5M+2.5% $100.0M-4.2% $104.4M+5.1% $99.4M
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses $94.9M+3.5% $91.7M+2.1% $89.8M-5.1% $94.6M-11.5% $106.9M+7.0% $100.0M+3.0% $97.0M-9.3% $106.9M
Operating Income -$29.4M-20053.4% -$146K+95.0% -$2.9M+79.2% -$14.1M-35.8% -$10.4M-50.7% -$6.9M+88.5% -$60.0M-286.6% -$15.5M
Interest Expense N/A N/A N/A N/A N/A N/A N/A N/A
Income Tax $1.1M+51.6% $711K+482.8% $122K-70.8% $418K-75.3% $1.7M+35.0% $1.3M-97.3% $46.5M+480.7% -$12.2M
Net Income -$31.5M-1545.9% -$1.9M-1097.5% -$160K+98.9% -$14.3M-22.6% -$11.7M-53.3% -$7.6M+92.7% -$104.7M-6066.7% -$1.7M
EPS (Diluted) N/A $-0.06-500.0% $-0.01+97.9% $-0.48 N/A $-0.26+92.5% $-3.45-6800.0% $-0.05

TBI Balance Sheet

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Total Assets $638.7M-7.5% $690.5M+2.6% $672.8M-2.8% $692.5M+2.5% $675.4M-3.8% $702.4M-2.9% $723.7M-16.7% $868.6M
Current Assets $297.6M-5.0% $313.2M+9.2% $286.9M+2.1% $281.0M+1.4% $277.1M-2.9% $285.3M-5.1% $300.6M-4.7% $315.4M
Cash & Equivalents $24.5M+23.2% $19.9M-9.2% $21.9M-5.0% $23.1M+2.3% $22.5M+55.4% $14.5M-45.1% $26.4M-27.0% $36.2M
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable $241.2M-4.2% $251.9M+11.6% $225.7M+3.1% $219.1M+2.0% $214.7M-4.7% $225.4M-2.5% $231.1M-5.4% $244.2M
Goodwill $42.5M+0.5% $42.3M-0.7% $42.6M+0.7% $42.3M+72.3% $24.5M-2.9% $25.3M+1.5% $24.9M-70.3% $83.9M
Total Liabilities $364.1M-5.7% $386.2M+5.1% $367.6M-5.8% $390.3M+8.4% $360.0M-4.1% $375.2M-2.8% $385.9M-8.6% $422.2M
Current Liabilities $138.5M-11.0% $155.7M+5.2% $148.1M-5.3% $156.3M-2.4% $160.1M+3.6% $154.6M-2.2% $158.0M-14.1% $184.0M
Long-Term Debt $65.8M-3.5% $68.2M+26.8% $53.8M-6.9% $57.8M+660.5% $7.6M N/A N/A N/A
Total Equity $274.6M-9.8% $304.3M-0.3% $305.2M+1.0% $302.2M-4.2% $315.4M-3.6% $327.2M-3.1% $337.8M-24.3% $446.4M
Retained Earnings $296.2M-9.2% $326.1M-0.2% $326.8M+0.7% $324.4M-3.9% $337.6M-2.8% $347.3M-3.1% $358.3M-23.3% $467.1M

TBI Cash Flow Statement

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Operating Cash Flow -$4.4M+77.9% -$19.8M-67.6% -$11.8M+46.7% -$22.1M-460.7% $6.1M+186.0% -$7.1M-290.9% -$1.8M+87.2% -$14.2M
Capital Expenditures $3.1M-13.6% $3.6M-15.0% $4.3M-9.1% $4.7M-11.3% $5.3M-5.7% $5.6M-5.2% $5.9M-19.9% $7.4M
Free Cash Flow -$7.5M+67.9% -$23.4M-45.7% -$16.1M+40.1% -$26.8M-3237.6% $854K+106.7% -$12.7M-64.6% -$7.7M+64.3% -$21.6M
Investing Cash Flow $30K-99.2% $3.7M-11.4% $4.2M+117.4% -$24.0M-2261.4% -$1.0M-126.2% $3.9M+162.2% -$6.2M-777.9% $919K
Financing Cash Flow -$2.4M-116.9% $14.5M+440.4% -$4.3M-108.6% $49.4M+543.0% $7.7M+280.8% -$4.2M+38.1% -$6.9M+49.8% -$13.7M
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks $0 $0 $0 $0+100.0% -$8K-100.2% $4.3M-37.6% $6.9M-31.3% $10.1M

TBI Financial Ratios

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Gross Margin 21.5%-1.2pp 22.7%-0.9pp 23.6%+0.3pp 23.3%-3.3pp 26.6%+0.4pp 26.2%-0.2pp 26.4%+1.7pp 24.7%
Operating Margin -7.0%-7.0pp -0.0%+0.7pp -0.7%+3.1pp -3.8%-1.1pp -2.7%-0.9pp -1.8%+13.3pp -15.1%-11.3pp -3.9%
Net Margin -7.5%-7.1pp -0.4%-0.4pp -0.0%+3.8pp -3.9%-0.9pp -3.0%-1.0pp -2.0%+24.4pp -26.4%-26.0pp -0.4%
Return on Equity -11.5%-10.9pp -0.6%-0.6pp -0.1%+4.7pp -4.8%-1.0pp -3.7%-1.4pp -2.3%+28.7pp -31.0%-30.6pp -0.4%
Return on Assets -4.9%-4.7pp -0.3%-0.3pp -0.0%+2.1pp -2.1%-0.3pp -1.7%-0.6pp -1.1%+13.4pp -14.5%-14.3pp -0.2%
Current Ratio 2.15+0.1 2.01+0.1 1.94+0.1 1.80+0.1 1.73-0.1 1.85-0.1 1.90+0.2 1.71
Debt-to-Equity 0.24+0.0 0.22+0.0 0.18-0.0 0.19+0.2 0.02-1.1 1.150.0 1.14+0.2 0.95
FCF Margin -1.8%+3.6pp -5.4%-1.4pp -4.0%+3.2pp -7.2%-7.5pp 0.2%+3.6pp -3.3%-1.4pp -1.9%+3.4pp -5.4%

Similar Companies

Frequently Asked Questions

Trueblue (TBI) reported $1.6B in total revenue for fiscal year 2025. This represents a 3.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Trueblue (TBI) revenue grew by 3.1% year-over-year, from $1.6B to $1.6B in fiscal year 2025.

No, Trueblue (TBI) reported a net income of -$48.0M in fiscal year 2025, with a net profit margin of -3.0%.

Trueblue (TBI) reported diluted earnings per share of $-1.61 for fiscal year 2025. This represents a 61.4% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Trueblue (TBI) had EBITDA of -$17.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Trueblue (TBI) had $24.5M in cash and equivalents against $65.8M in long-term debt.

Trueblue (TBI) had a gross margin of 22.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Trueblue (TBI) had an operating margin of -2.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Trueblue (TBI) had a net profit margin of -3.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Trueblue (TBI) has a return on equity of -17.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Trueblue (TBI) generated -$73.7M in free cash flow during fiscal year 2025. This represents a -78.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Trueblue (TBI) generated -$58.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Trueblue (TBI) had $638.7M in total assets as of fiscal year 2025, including both current and long-term assets.

Trueblue (TBI) invested $15.7M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Trueblue (TBI) had 30M shares outstanding as of fiscal year 2025.

Trueblue (TBI) had a current ratio of 2.15 as of fiscal year 2025, which is generally considered healthy.

Trueblue (TBI) had a debt-to-equity ratio of 0.24 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Trueblue (TBI) had a return on assets of -7.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2025 data, Trueblue (TBI) had $24.5M in cash against an annual operating cash burn of $58.0M. This gives an estimated cash runway of approximately 5 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Trueblue (TBI) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Trueblue (TBI) has an earnings quality ratio of 1.21x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Trueblue (TBI) scores 34 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top